TTP is a rare disease that clinicians may not often treat; however, it is important to be aware of new developments for the treatment of this patient population.
The use of Ikari-curve left guiding catheters during balloon pulmonary angioplasty was found to allow access to branches not accessible with conventional guiding catheters.
Pulmonary vein sign was found to be easy to detect and to have higher sensitivity and specificity in chronic thromboembolic pulmonary hypertension compared with acute pulmonary embolism.
There might be notable variations among hematology, oncology, and bone marrow transplant practitioners when treating thrombotic events in children with leukemia.
Patients with sickle cell disease may have an increased risk for venous thromboembolic events, especially pulmonary embolism, following surgical splenectomy.
Researchers reported a safe and effective treatment strategy to prevent clot progression in neonates and children with catheter-related arterial thrombosis.
